Advertisement

Topics

Adaptive Phage Therapeutics, Inc. Company Profile

11:13 EDT 18th June 2019 | BioPortfolio


News Articles [1074 Associated News Articles listed on BioPortfolio]

Adaptive Phage Therapeutics Enters into Collaboration Agreement with Researchers at Yale University to Manufacture and Supply Therapeutic Bacteriophage

Adaptive Phage Therapeutics (APT), a clinical-stage biotechnology company founded to provide an effective therapeutic response to the global rise of multi-drug resistant (MDR) pat...

CORRECTING and REPLACING Adaptive Phage Therapeutics Enters into Collaboration Agreement with Researchers at Yale University to Manufacture and Supply Therapeutic Bacteriophage

Second paragraph, first sentence of release dated December 12, 2018, should read: ... Food and Drug Administration (instead of...Federal Drug Administration). The ...

Just a phage? How bacteria's predators can shape the gut microbiome

(Brigham and Women's Hospital) A phage can have a profound impact on the dynamics of the gut microbiome, not only affecting certain species directly but also having a cascading effect on others. Phage...

Phage Therapy Win: Mycobacterium Infection Halted

When Graham Hatfull, PhD, a professor at the University of Pittsburgh specializing in phage biology and James Soothill, MD, microbiologist at Great Ormond Street Hospital for Children (GOHS) in Londo...

Phage therapy’s latest makeover. As issues of product consistency, standardization and specificity are being tackled, can #phage therapeutics—long oversold and overhyped—finally realize their #antibacterial potential? https://go.nature.com/2Juj08e

Phage therapy’s latest makeover. As issues of product consistency, standardization and specificity are being tackled, can #phage therapeutics—long oversold and overhyped—finally rea...

Genentech, Adaptive Bio Join Forces on Personalized Cancer Drugs R&D

Genentech is paying Adaptive Biotechnologies $300 million up front in a new partnership focused on developing cancer immunotherapies personalized to individual patients. Seattle-based Adaptive has tec...

Phage Therapy: Turning the Tables on Bacteria

CRISPR is a double-edged sword. It evolved to help bacteria slay phages. But CRISPR components can also be engineered into phages, arming them against bacteria. Consequently, phage therapy says, “En...

Baldo Leaves Genentech for Adaptive Bio Chief Medical Officer Post

Adaptive Biotechnologies has appointed Lance Baldo to serve as its chief medical officer. Baldo comes to Seattle-based Adaptive from Roche subsidiary Genentech, where he was senior vice president and ...

Drugs and Medications [27 Associated Drugs and Medications listed on BioPortfolio]

Kynamro [kastle therapeutics, llc]

NA

Olopatadine hydrochloride [somerset therapeutics, llc]

OLOPATADINE Hydrochloride Ophthalmic Solution USP, 0.1%Somerset Therapeutics, LLC

Oxygen [breathe easy therapeutics, inc]

NA

Diclofenac sodium delayed release [cambridge therapeutics technologies, llc]

Diclofenac Sodium

Olopatadine hydrochloride [a-s medication solutions]

OLOPATADINE Hydrochloride Ophthalmic Solution USP, 0.1%Somerset Therapeutics, LLC

PubMed Articles [1059 Associated PubMed Articles listed on BioPortfolio]

The dawn of phage therapy.

Bacteriophages or phages, being the most abundant entities on earth, represent a potential solution to a diverse range of problems. Phages are successful antibacterial agents whose use in therapeutics...

Utilizing in vitro DNA assembly to engineer a synthetic T7 Nanoluc reporter phage for Escherichia coli detection.

Bacteria have major role in regulating human health and disease, therefore, there is a continuing need to develop new detection methods and therapeutics to combat them. Bacteriophages can be used to i...

The Promising Viral Threat to Bacterial Resistance: the Uncertain Patentability of Phage Therapeutics and the Necessity of Alternative Incentives.

Bacteriophages, or "phages," are a category of highly adept and adaptable viruses that can infect and kill bacteria. With concerns over the burgeoning antibiotic-resistance crisis looming in recent ye...

Crowd Controlled-Host Quorum Sensing Drives Phage Decision.

In the January issue of Cell, Silpe and Bassler (2019) characterize a phage that looks beyond the boundaries of infected host cells by directly wiretapping their intercellular communication. This info...

Phage display derived therapeutic antibodies have enriched aliphatic content: Insights for developability issues.

Phage display is one of the most widely used technology for antibody discovery and engineering. Number of therapeutic antibodies derived from phage display increases rapidly due to its ease of use and...

Clinical Trials [788 Associated Clinical Trials listed on BioPortfolio]

Evaluation and Detection of Facial Propionibacterium Acnes Bacteria and Phage

This multi-center, outpatient study will extract and evaluate the presence of facial P. acnes bacteria and phage strains using pore strips on up to 400 human subjects.

Ascending Dose Study of the Safety of AB-SA01 When Topically Applied to Intact Skin of Healthy Adults

This study will examine the safety of ascending doses of AB-SA01 when topically applied to intact skin of healthy adults.

Shrinking Target Adaptive Radiotherapy for Locally Advanced Non-Small Cell Lung Cancer

This study aims to use a type of radiation (adaptive radiotherapy) to deliver curative-intent treatment to patients with non-small cell lung cancer, whose tumors would otherwise be too lar...

Adaptive Cardiac Resynchronization Therapy Study

The purpose of this study is to show that Adaptive CRT is at least as good at optimizing a patient's cardiac resynchronization therapy (CRT) as the current method of using an echocardiogra...

Impact of Ibis on Patients With Advanced COPD

The purpose of this research is to determine if Ibis™, a digital therapeutics solution developed by Senscio Systems, reduces the emergency room visits and hospitalizations of patients wi...

Companies [1421 Associated Companies listed on BioPortfolio]

Adaptive Phage Therapeutics (APT)

Adaptive Phage Therapeutics, Inc. (APT) is a clinical-stage company founded to provide an effective therapeutic response to the global rise of multi-drug resistant (MDR) pathogeni...

Adaptive Phage Therapeutics, Inc.

Adaptive Phage Therapeutics, Inc.

Adaptive Corporation

Adaptive Corporation is a leading provider of Business Process Automation and Product Development technology and services. The company helps its customers become market leaders th...

Mercator Therapeutics, Inc.

Mercator Therapeutics is the first biopharmaceutical company to use in vivo phage display technology systematically to develop novel cancer drugs. Mercator was founded to translat...

More Information about "Adaptive Phage Therapeutics, Inc." on BioPortfolio

We have published hundreds of Adaptive Phage Therapeutics, Inc. news stories on BioPortfolio along with dozens of Adaptive Phage Therapeutics, Inc. Clinical Trials and PubMed Articles about Adaptive Phage Therapeutics, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Adaptive Phage Therapeutics, Inc. Companies in our database. You can also find out about relevant Adaptive Phage Therapeutics, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record